July 2, 2024
Share on PinterestEating a healthy diet when you’re younger may help boost brain health and reduce your risk of cognitive decline as you age. Photography by […]
July 2, 2024
The US Food and Drug Administration (FDA) has approved Eli Lilly’s anti-amyloid donanemab (Kisunla) 350 mg/20 mL once-monthly injection for intravenous infusion for adults with early […]
July 2, 2024
On this page Who is the audience for this webpage? FDA’s patient labeling specific resources on this webpage are primarily directed to industry staff who develop […]
July 2, 2024
Host: Captain Mary KremznerPharmacist: Lieutenant Lindsay Davison CAPT Kremzner: Traveling with prescription medications. How can you avoid travel delays upon arrival to, and departure from, the […]
July 2, 2024
Authority The Genetic Metabolic Diseases Advisory Committee (GeMDAC) (the Committee) is established under 15 U.S.C. 1451 et seq.; 21 U.S.C. 321, 341, 342, 343, 343-1, 344, […]
July 2, 2024
Applying for Membership on FDA Advisory Committees As part of the Food and Drug Administration’s (FDA’s) ongoing efforts to recruit qualified experts with minimal conflicts of […]
July 2, 2024
Action The U.S. Food and Drug Administration has approved Kisunla (donanemab-azbt) injection for the treatment of Alzheimer’s disease. Treatment with Kisunla should be initiated in patients […]
July 2, 2024
FDA is warning health care professionals and pharmacies to avoid using Hospira’s unapproved potassium phosphates drug product in pediatric patients because the aluminum exposure from this […]
July 2, 2024
Eight commonly used antidepressants have been ranked by their weight gain potential. Results of a large observational study showed small differences in short- and long-term weight […]